Precision Therapeutics Announces Record STREAMWAY System Sales in the First Three Months of 2018 Medical Device Investing
Solid Biosciences Reports Full Year 2017 Financial Results and Provides Corporate Update Biotech Investing
Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse Pharmaceutical Investing
Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update Pharmaceutical Investing
Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC Pharmaceutical Investing
Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment Genetics Investing
Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update Pharmaceutical Investing
pSivida Announces Transformative Acquisition of Icon Bioscience and Growth Capital Financing with Essex Woodlands Healthcare Partners Pharmaceutical Investing
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
